Your search returned 9 results.

Results
	1.	Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML. [electronic resource] by Sison, Edward Allan R McIntyre, Emily Magoon, Daniel Brown, Patrick Producer: 20140318 In: Molecular cancer research : MCR vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition. [electronic resource] by Sison, Edward Allan R Magoon, Daniel Li, Li Annesley, Colleen E Rau, Rachel E Small, Donald Brown, Patrick Producer: 20150807 In: Oncotarget vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL. [electronic resource] by Sison, Edward Allan R Magoon, Daniel Li, Li Annesley, Colleen E Romagnoli, Barbara Douglas, Garry J Tuffin, Gerald Zimmermann, Johann Brown, Patrick Producer: 20160823 In: Oncotarget vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Knock-in of the [electronic resource] by Annesley, Colleen E Rabik, Cara Duffield, Amy S Rau, Rachel E Magoon, Daniel Li, Li Huff, Vicki Small, Donald Loeb, David M Brown, Patrick Publication details: Oncotarget Oct 2018 In: Oncotarget vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011). [electronic resource] by Loh, Mignon L Tasian, Sarah K Rabin, Karen R Brown, Patrick Magoon, Daniel Reid, Joel M Chen, Xuejun Ahern, Charlotte H Weigel, Brenda J Blaney, Susan M Producer: 20151102 In: Pediatric blood & cancer vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	NPMc+ cooperates with Flt3/ITD mutations to cause acute leukemia recapitulating human disease. [electronic resource] by Rau, Rachel Magoon, Daniel Greenblatt, Sarah Li, Li Annesley, Colleen Duffield, Amy S Huso, David McIntyre, Emily Clohessy, John G Reschke, Markus Pandolfi, Pier Paolo Small, Donald Brown, Patrick Producer: 20140411 In: Experimental hematology vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03). [electronic resource] by Cooper, Todd M Sison, Edward Allan Racela Baker, Sharyn D Li, Lie Ahmed, Amina Trippett, Tanya Gore, Lia Macy, Margaret E Narendran, Aru August, Keith Absalon, Michael J Boklan, Jessica Pollard, Jessica Magoon, Daniel Brown, Patrick A Producer: 20170914 In: Pediatric blood & cancer vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study. [electronic resource] by Cooper, Todd M Cassar, Jeannette Eckroth, Elena Malvar, Jemily Sposto, Richard Gaynon, Paul Chang, Bill H Gore, Lia August, Keith Pollard, Jessica A DuBois, Steven G Silverman, Lewis B Oesterheld, Javier Gammon, Guy Magoon, Daniel Annesley, Colleen Brown, Patrick A Producer: 20180112 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. [electronic resource] by Zuber, Johannes Shi, Junwei Wang, Eric Rappaport, Amy R Herrmann, Harald Sison, Edward A Magoon, Daniel Qi, Jun Blatt, Katharina Wunderlich, Mark Taylor, Meredith J Johns, Christopher Chicas, Agustin Mulloy, James C Kogan, Scott C Brown, Patrick Valent, Peter Bradner, James E Lowe, Scott W Vakoc, Christopher R Producer: 20120126 In: Nature vol. 478 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)